January 09, 2025 03:21 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes | Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her
Hetero receives emergency use nod by DCGI for Covid drug Tocilizumab

Hetero receives emergency use nod by DCGI for Covid drug Tocilizumab

Sep 06, 2021, at 08:46 pm

Hyderabad/UNI: Hetero, the Hyderabad-based pharma major, announced on Monday that the Drugs Controller General of India (DCGI) has issued approval for restricted use, Emergency Use Authorization (EUA) for the generic version of Tocilizumab in India.